Jie Li

Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China

Anwen Xiong, Lei Wang, Jianhua Chen et al. · The Lancet · 2025 · 133 citations

Medicine, Oncology, Pharmacology +13

Effects of pore size on <i>in vitro</i> and <i>in vivo</i> anticancer efficacies of mesoporous silica nanoparticles

Jie Li, Suqin Shen, Fei Kong et al. · RSC Advances · 2018 · 79 citations · Full text

Pharmacy, Materials Science, Pharmaceutics +17

Smart Nanosensitizers for Activatable Sono‐Photodynamic Immunotherapy of Tumors by Redox‐Controlled Disassembly

Lingjun Liu, Junya Zhang, Ruibing An et al. · Angewandte Chemie International Edition · 2023 · 75 citations

Pharmacy, Cancer Biology, Oncology +17

Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin

Jie Li, Huamin Zeng, Rongrong Wang et al. · Journal of Nanobiotechnology · 2021 · 74 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Smart gold nanoparticles enhance killing effect on cancer cells

Kun Song, Peng Xu, Yongde Meng et al. · International Journal of Oncology · 2012 · 67 citations

Medicine, Oncology, Radiation Oncology +17